A recent study on the enzyme S-1117, an Fc-fused IgG degrading enzyme, has demonstrated significant potential for further development in the realm of therapeutic applications. The chronic dosing of S-1117 in mice revealed an encouraging safety profile, a crucial milestone that paves the way for future biotechnological advancements and novel disease treatments. S-1117 has shown […]